H. Lenk

834 total citations
36 papers, 620 citations indexed

About

H. Lenk is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, H. Lenk has authored 36 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 11 papers in Genetics and 6 papers in Surgery. Recurrent topics in H. Lenk's work include Hemophilia Treatment and Research (17 papers), Platelet Disorders and Treatments (15 papers) and Chronic Myeloid Leukemia Treatments (5 papers). H. Lenk is often cited by papers focused on Hemophilia Treatment and Research (17 papers), Platelet Disorders and Treatments (15 papers) and Chronic Myeloid Leukemia Treatments (5 papers). H. Lenk collaborates with scholars based in Germany, United States and Sweden. H. Lenk's co-authors include Jean‐Marie Saint‐Remy, Jos Vermylen, Johannes Oldenburg, Karin Kurnik, I. Scharrer, G Weissbach, W. Kreuz, Sylvia von Mackensen, Rosario Garrido and M Vicariot and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

H. Lenk

33 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Lenk Germany 13 545 161 52 44 34 36 620
Elena Santagostino Italy 10 498 0.9× 129 0.8× 47 0.9× 16 0.4× 67 2.0× 13 591
Suzy Maria Teresa Durazzi Italy 4 413 0.8× 373 2.3× 45 0.9× 18 0.4× 39 1.1× 7 572
J.M. Lusher United States 8 773 1.4× 179 1.1× 152 2.9× 11 0.3× 49 1.4× 13 849
M Vicariot France 9 386 0.7× 132 0.8× 98 1.9× 7 0.2× 18 0.5× 24 503
Cristiano Gallucci Italy 12 229 0.4× 207 1.3× 27 0.5× 19 0.4× 39 1.1× 25 446
Masahiro Takeyama Japan 12 406 0.7× 141 0.9× 22 0.4× 50 1.1× 43 1.3× 64 477
Kagehiro Amano Japan 16 690 1.3× 247 1.5× 109 2.1× 41 0.9× 15 0.4× 84 765
M Pepe United States 7 382 0.7× 78 0.5× 15 0.3× 40 0.9× 32 0.9× 11 477
Sandrine Meunier France 12 346 0.6× 92 0.6× 171 3.3× 19 0.4× 51 1.5× 45 578
Venée N. Tubman United States 11 269 0.5× 235 1.5× 52 1.0× 16 0.4× 10 0.3× 34 379

Countries citing papers authored by H. Lenk

Since Specialization
Citations

This map shows the geographic impact of H. Lenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lenk more than expected).

Fields of papers citing papers by H. Lenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Lenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lenk. The network helps show where H. Lenk may publish in the future.

Co-authorship network of co-authors of H. Lenk

This figure shows the co-authorship network connecting the top 25 collaborators of H. Lenk. A scholar is included among the top collaborators of H. Lenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Lenk. H. Lenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, R., et al.. (2012). [Haemophilia treatment centres in Germany].. PubMed. 32 Suppl 1. S12–9. 1 indexed citations
2.
Ivaškevičius, Vytautas, Arijit Biswas, Carville G. Bevans, et al.. (2010). Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica. 95(6). 956–962. 36 indexed citations
3.
Utsch, Boris, Analisa DiFeo, Stephanie M. Karle, et al.. (2006). Bladder exstrophy and Epstein type congenital macrothrombocytopenia: Evidence for a common cause?. American Journal of Medical Genetics Part A. 140A(20). 2251–2253. 8 indexed citations
4.
Sorge, Ina, et al.. (2005). Acute Portal Vein Thrombosis after Splenic Embolization and Splenectomy for Autoimmune Pancytopenia. European Journal of Pediatric Surgery. 15(5). 358–360. 3 indexed citations
5.
Gringeri, A., Sylvia von Mackensen, Günter Auerswald, et al.. (2004). Health status and health‐related quality of life of children with haemophilia from six West European countries. Haemophilia. 10(s1). 26–33. 91 indexed citations
6.
Lenk, H., Tobias Obser, Johannes Oldenburg, et al.. (2004). Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization. Thrombosis and Haemostasis. 92(7). 36–41. 19 indexed citations
7.
Auerswald, G., M. von Depka Prondzinski, B. Ehlken, et al.. (2004). Treatment patterns and cost‐of‐illness of severe haemophilia in patients with inhibitors in Germany. Haemophilia. 10(5). 499–508. 39 indexed citations
8.
Astermark, Jan, Jan Voorberg, H. Lenk, et al.. (2003). Impact of inhibitor epitope profile on the neutralizing effect against plasma‐derived and recombinant factor VIII concentrates in vitro. Haemophilia. 9(5). 567–572. 43 indexed citations
9.
10.
Klinge, J., G. Auerswald, Ulrich Budde, et al.. (2001). Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay. Haemophilia. 7(1). 26–32. 11 indexed citations
11.
Lenk, H.. (1999). The German National Immune Tolerance Registry, 1997 Update. Vox Sanguinis. 77(Suppl. 1). 28–30. 31 indexed citations
12.
Lenk, H.. (1999). The German National Immune Tolerance Registry, 1997 Update. Vox Sanguinis. 77(S1). 28–30. 1 indexed citations
13.
Lenk, H., et al.. (1999). Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: Is there a clinical relevance?. European Journal of Pediatrics. 158(S3). S177–S179. 2 indexed citations
14.
15.
Liebert, Uwe G., et al.. (1998). Zur Klinik und Epidemiologie der Hepatitis C bei immunsupprimierten Kindern mit vorwiegend onkologischen Erkrankungen. Klinische Pädiatrie. 210(4). 274–278. 6 indexed citations
16.
Lenk, H., et al.. (1996). Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.. Journal of Clinical Investigation. 97(6). 1382–1388. 59 indexed citations
17.
Donnér, Mikael, H. Lenk, E. Scheibel, et al.. (1992). Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden. British Journal of Haematology. 82(1). 58–65. 18 indexed citations
18.
Lenk, H., Inga Marie Nilsson, Lars Holmberg, & G Weissbach. (1988). Frequency of Different Types of von Willebrand's Disease in the GDR. Acta Medica Scandinavica. 224(3). 275–280. 14 indexed citations
19.
Weissbach, G, et al.. (1985). [Iliopsoas hemorrhage in hemophilic children].. PubMed. 112(6). 834–44. 1 indexed citations
20.
Weissbach, G, et al.. (1977). [Effect of drug therapy during pregnancy on the clotting potential of the newborn].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 99(8). 473–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Santagostino Breakdown of academic impact, for papers by Suzy Maria Teresa Durazzi Breakdown of academic impact, for papers by J.M. Lusher Breakdown of academic impact, for papers by M Vicariot Breakdown of academic impact, for papers by Cristiano Gallucci Breakdown of academic impact, for papers by Masahiro Takeyama Breakdown of academic impact, for papers by Kagehiro Amano Breakdown of academic impact, for papers by M Pepe Breakdown of academic impact, for papers by Sandrine Meunier Breakdown of academic impact, for papers by Venée N. Tubman
Rankless by CCL
2026